true
Vaccine syringes

BD Hypak™ for Vaccines Glass Prefillable Syringe System

BD tools for vaccine combination product developers

hypak for vaccines banner
Loading
Overview

BD HypakTM for Vaccines Glass Prefillable Syringe System selected by the top 5 vaccine pharmaceutical companies1 2:

  • key specifications are adapted to the current needs of vaccine manufacturing.3
  • minimized risk of deviation through In-Process Controls implemented at critical steps of the manufacturing process.3
hypak vaccine prefillable glass syringes RC PS PSP 0616 0022

hypak vaccine prefillable glass syringes C PS PSP 0616 0019

hypak vaccine prefillable glass syringes C PS PSP 0616 0020

hypak vaccine prefillable glass syringes C PS PSP 0616 0021

hypak vaccine prefillable glass syringes RC PS PSP 0616 0022
hypak vaccine prefillable glass syringes C PS PSP 0616 0019
hypak vaccine prefillable glass syringes C PS PSP 0616 0020
hypak vaccine prefillable glass syringes C PS PSP 0616 0021
Features and Benefits

BD HypakTM for Vaccines Glass Prefillable Syringe Features

  • Flange optimal resistance2
  • Prevents rolling*

BD HypakTM for Vaccines Glass Prefillable Syringe Benefits

  • Key specifications adapted to the current needs of vaccine manufacturing3
  • Minimized risk of deviation through In-Process Controls implemented at critical steps of the manufacturing process3
  • Multi-sourcing network for business continuity
  • 30 reference available: staked needle or luer tip, different flanges, tip or needle caps, etc.

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:

Endnotes

* BD tools for vaccine combination product developers. 

References

  1. Market analysis and product sales for Vaccines, from 2014 to 2018 [internal analysis]. Pont de Claix, FR: Becton, Dickinson and Company; 2019
  2. Vaccines Market Leaders, https://www.statista.com/statistics/314562/leading-global-pharmaceuticalcompanies-by-vaccine-revenue/ accessed 4th April 2018
  3. BD HypakTM for vaccines needle design verification rationale [internal study]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2013

BD Expertise in Galss Prefilable Syringe for Vaccines

Our expertise in BD HypakTM for Vaccines Glass Prefillable Syringe 

  • Nearly 3 billion units sold since launch4
  • Selected by the top 5 vaccine pharmaceutical companies 1,2
  • BD is uniquely positioned with high volume production capacity delivering hundreds of millions4 of BD HypakTM for Vaccines each year

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:

References

  1. Market analysis and product sales for Vaccines, from 2014 to 2018 [internal analysis]. Pont de Claix, FR: Becton, Dickinson and Company; 2019
  2. Vaccines Market Leaders, https://www.statista.com/statistics/314562/leading-global-pharmaceuticalcompanies-by-vaccine-revenue/ accessed 4th April 2018
  3. BD HypakTM for vaccines needle design verification rationale [internal study]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2013
  4. BD sales analysis [internal analysis]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2019
  5. BD-PS external communication to customers - BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years https://news.bd.com/2020-12-02-BD-to-Invest-1-2-Billion-in-Pre-Fillable-Syringe-Manufacturing-Capacity-Over-Next-Four-Years/Accessed Dec. 2, 2020

BD Hypak™ for Vaccines Glass Prefillable Syringe availability

  • Will benefit from BD long-term capacity extension program with investment of over USD 1.2 billion for ready-to-administer containers for injectable drugs1
  • Samples available on demand
  • Commercial availability to be evaluated against requirements.

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:

References

  1. BD-PS external communication to customers - BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years https://news.bd.com/2020-12-02-BD-to-Invest-1-2-Billion-in-Pre-Fillable-Syringe-Manufacturing-Capacity-Over-Next-Four-Years/Accessed Dec. 2, 2020

Related Product Families

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Resources
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
true

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Access our BD Webinar portal
true